Brief: Takeda Pharmaceutical To Discontinue Its Cell Therapy Efforts

Takeda Pharmaceutical

01/10/2025 15:29

Oct 1 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:

TAKEDA PHARMACEUTICAL CO LTD - TO DISCONTINUE ITS CELL THERAPY EFFORTS

TAKEDA PHARMACEUTICAL CO LTD - IN Q2, CO EXPECTS TO RECOGNIZE AN IMPAIRMENT LOSS OF APPROXIMATELY JPY 58.0 BILLION

TAKEDA PHARMACEUTICAL CO LTD - WILL SEEK AN EXTERNAL PARTNER TO LEVERAGE ITS CELL THERAPY PLATFORM TECHNOLOGIES

Source text: [ID:n0001395064-25-000145]

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))